We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Voyager Therapeutics (VYGR) in Focus: Stock Rises 9.4%
Read MoreHide Full Article
Voyager Therapeutics, Inc. (VYGR - Free Report) was a big mover last session, as its shares rose over 9% on the day. The move came after the company announced positive interim results from Phase 1b Trial of VY-AADC01 for advanced Parkinson’s Disease. This led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $11.89 to $14.71 in the past one-month time frame.
Over the last 30 days, the company witnessed five positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Voyager Therapeutics carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Is VYGR going up? Or down? Predict to see what others think: Up or Down
The Best Place to Start Your Stock Search
Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Voyager Therapeutics (VYGR) in Focus: Stock Rises 9.4%
Voyager Therapeutics, Inc. (VYGR - Free Report) was a big mover last session, as its shares rose over 9% on the day. The move came after the company announced positive interim results from Phase 1b Trial of VY-AADC01 for advanced Parkinson’s Disease. This led to far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $11.89 to $14.71 in the past one-month time frame.
Over the last 30 days, the company witnessed five positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Voyager Therapeutics carries a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
VOYAGER THERAPT Price
VOYAGER THERAPT Price | VOYAGER THERAPT Quote
A similarly-ranked stock in the medical-generic drugs space is Aquinox Pharmaceuticals, Inc. , also carrying a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Is VYGR going up? Or down? Predict to see what others think: Up or Down
The Best Place to Start Your Stock Search
Today, you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buy" stocks – absolutely free of charge. Since 1988, Zacks Rank #1 stocks have nearly tripled the market, with average gains of +26% per year. Plus, you can access the list of portfolio-killing Zacks Rank #5 "Strong Sells" and other private research. See these stocks free >>